Financials
- Market Capitalization 226.34 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.79
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3478 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 14.06 USD | -0.28% | +2.93% | +38.39% | -6.33% | 241.14 M USD | ||
| 3495 | RNA Atrium Therapeutics, Inc. - Common Stock | 13.78 USD | +3.45% | +0.51% | +20.35% | -80.41% | 235.72 M USD | ||
| 3542 | PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.11 USD | -0.94% | -7.05% | +21.97% | -5.80% | 222.31 M USD | ||
| 3545 | NERV Minerva Neurosciences, Inc - Common Stock | 4.64 USD | +1.75% | -7.75% | +17.47% | +97.45% | 221.55 M USD |